577 related articles for article (PubMed ID: 28089566)
1. Metformin Inhibits Hepatic mTORC1 Signaling via Dose-Dependent Mechanisms Involving AMPK and the TSC Complex.
Howell JJ; Hellberg K; Turner M; Talbott G; Kolar MJ; Ross DS; Hoxhaj G; Saghatelian A; Shaw RJ; Manning BD
Cell Metab; 2017 Feb; 25(2):463-471. PubMed ID: 28089566
[TBL] [Abstract][Full Text] [Related]
2. AMPK regulation of Raptor and TSC2 mediate metformin effects on transcriptional control of anabolism and inflammation.
Van Nostrand JL; Hellberg K; Luo EC; Van Nostrand EL; Dayn A; Yu J; Shokhirev MN; Dayn Y; Yeo GW; Shaw RJ
Genes Dev; 2020 Oct; 34(19-20):1330-1344. PubMed ID: 32912901
[TBL] [Abstract][Full Text] [Related]
3. Ciclopirox olamine inhibits mTORC1 signaling by activation of AMPK.
Zhou H; Shang C; Wang M; Shen T; Kong L; Yu C; Ye Z; Luo Y; Liu L; Li Y; Huang S
Biochem Pharmacol; 2016 Sep; 116():39-50. PubMed ID: 27396756
[TBL] [Abstract][Full Text] [Related]
4. Neuronal Tsc1/2 complex controls autophagy through AMPK-dependent regulation of ULK1.
Di Nardo A; Wertz MH; Kwiatkowski E; Tsai PT; Leech JD; Greene-Colozzi E; Goto J; Dilsiz P; Talos DM; Clish CB; Kwiatkowski DJ; Sahin M
Hum Mol Genet; 2014 Jul; 23(14):3865-74. PubMed ID: 24599401
[TBL] [Abstract][Full Text] [Related]
5. Renal tumours in a Tsc1+/- mouse model show epigenetic suppression of organic cation transporters Slc22a1, Slc22a2 and Slc22a3, and do not respond to metformin.
Yang J; Kalogerou M; Gallacher J; Sampson JR; Shen MH
Eur J Cancer; 2013 Apr; 49(6):1479-90. PubMed ID: 23228442
[TBL] [Abstract][Full Text] [Related]
6. Energy depletion of bovine mammary epithelial cells activates AMPK and suppresses protein synthesis through inhibition of mTORC1 signaling.
Burgos SA; Kim JJ; Dai M; Cant JP
Horm Metab Res; 2013 Mar; 45(3):183-9. PubMed ID: 22972179
[TBL] [Abstract][Full Text] [Related]
7. Metformin, independent of AMPK, inhibits mTORC1 in a rag GTPase-dependent manner.
Kalender A; Selvaraj A; Kim SY; Gulati P; Brûlé S; Viollet B; Kemp BE; Bardeesy N; Dennis P; Schlager JJ; Marette A; Kozma SC; Thomas G
Cell Metab; 2010 May; 11(5):390-401. PubMed ID: 20444419
[TBL] [Abstract][Full Text] [Related]
8. Cell-type-dependent regulation of mTORC1 by REDD1 and the tumor suppressors TSC1/TSC2 and LKB1 in response to hypoxia.
Wolff NC; Vega-Rubin-de-Celis S; Xie XJ; Castrillon DH; Kabbani W; Brugarolas J
Mol Cell Biol; 2011 May; 31(9):1870-84. PubMed ID: 21383064
[TBL] [Abstract][Full Text] [Related]
9. Metformin induces autophagy and G0/G1 phase cell cycle arrest in myeloma by targeting the AMPK/mTORC1 and mTORC2 pathways.
Wang Y; Xu W; Yan Z; Zhao W; Mi J; Li J; Yan H
J Exp Clin Cancer Res; 2018 Mar; 37(1):63. PubMed ID: 29554968
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis C virus inhibits AKT-tuberous sclerosis complex (TSC), the mechanistic target of rapamycin (MTOR) pathway, through endoplasmic reticulum stress to induce autophagy.
Huang H; Kang R; Wang J; Luo G; Yang W; Zhao Z
Autophagy; 2013 Feb; 9(2):175-95. PubMed ID: 23169238
[TBL] [Abstract][Full Text] [Related]
11. AMP-activated Protein Kinase (AMPK) Control of mTORC1 Is p53- and TSC2-independent in Pemetrexed-treated Carcinoma Cells.
Agarwal S; Bell CM; Rothbart SB; Moran RG
J Biol Chem; 2015 Nov; 290(46):27473-86. PubMed ID: 26391395
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-451 regulates AMPK/mTORC1 signaling and fascin1 expression in HT-29 colorectal cancer.
Chen MB; Wei MX; Han JY; Wu XY; Li C; Wang J; Shen W; Lu PH
Cell Signal; 2014 Jan; 26(1):102-9. PubMed ID: 23899558
[TBL] [Abstract][Full Text] [Related]
13. Sustained activation of mTORC1 in macrophages increases AMPKα-dependent autophagy to maintain cellular homeostasis.
Pan H; Zhong XP; Lee S
BMC Biochem; 2016 Jul; 17(1):14. PubMed ID: 27387347
[TBL] [Abstract][Full Text] [Related]
14. Tuberous sclerosis complex inactivation disrupts melanogenesis via mTORC1 activation.
Cao J; Tyburczy ME; Moss J; Darling TN; Widlund HR; Kwiatkowski DJ
J Clin Invest; 2017 Jan; 127(1):349-364. PubMed ID: 27918305
[TBL] [Abstract][Full Text] [Related]
15. Hepatic mTORC1 controls locomotor activity, body temperature, and lipid metabolism through FGF21.
Cornu M; Oppliger W; Albert V; Robitaille AM; Trapani F; Quagliata L; Fuhrer T; Sauer U; Terracciano L; Hall MN
Proc Natl Acad Sci U S A; 2014 Aug; 111(32):11592-9. PubMed ID: 25082895
[TBL] [Abstract][Full Text] [Related]
16. Dose-Dependent AMPK-Dependent and Independent Mechanisms of Berberine and Metformin Inhibition of mTORC1, ERK, DNA Synthesis and Proliferation in Pancreatic Cancer Cells.
Ming M; Sinnett-Smith J; Wang J; Soares HP; Young SH; Eibl G; Rozengurt E
PLoS One; 2014; 9(12):e114573. PubMed ID: 25493642
[TBL] [Abstract][Full Text] [Related]
17. In vitro antiglioma action of indomethacin is mediated via AMP-activated protein kinase/mTOR complex 1 signalling pathway.
Pantovic A; Bosnjak M; Arsikin K; Kosic M; Mandic M; Ristic B; Tosic J; Grujicic D; Isakovic A; Micic N; Trajkovic V; Harhaji-Trajkovic L
Int J Biochem Cell Biol; 2017 Feb; 83():84-96. PubMed ID: 27988363
[TBL] [Abstract][Full Text] [Related]
18. AMPK activation prevents excess nutrient-induced hepatic lipid accumulation by inhibiting mTORC1 signaling and endoplasmic reticulum stress response.
Li H; Min Q; Ouyang C; Lee J; He C; Zou MH; Xie Z
Biochim Biophys Acta; 2014 Sep; 1842(9):1844-54. PubMed ID: 25016145
[TBL] [Abstract][Full Text] [Related]
19. mTOR Hyperactivation by Ablation of Tuberous Sclerosis Complex 2 in the Mouse Heart Induces Cardiac Dysfunction with the Increased Number of Small Mitochondria Mediated through the Down-Regulation of Autophagy.
Taneike M; Nishida K; Omiya S; Zarrinpashneh E; Misaka T; Kitazume-Taneike R; Austin R; Takaoka M; Yamaguchi O; Gambello MJ; Shah AM; Otsu K
PLoS One; 2016; 11(3):e0152628. PubMed ID: 27023784
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis B virus (HBV) X protein-mediated regulation of hepatocyte metabolic pathways affects viral replication.
Bagga S; Rawat S; Ajenjo M; Bouchard MJ
Virology; 2016 Nov; 498():9-22. PubMed ID: 27529294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
